| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.03 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.071 | 0.03 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.04 |